Списък на научните публикации на Проф. Д-р Захарий Александров Кръстев, дмн
СПИСЪК НА ЦИТАТИТЕ В МЕЖДУНАРОДНИ СПЕЦИАЛИЗИРАНИ НАУЧНИ ИЗДАНИЯ
Изтегляне 0.82 Mb.
|
- Навигация на страницата:
- Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis
- Jacobs, J.J., Characiejus, D., Scheper, R.J., Stewart, R.J., Tan, J.F., Tomova, R., Krastev, Z., Den Otter, W.
- Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B (2008) New England Journal of Medicine, 359 (23), pp. 2442-2455. Cited 109 times.
СПИСЪК НА ЦИТАТИТЕ В МЕЖДУНАРОДНИ СПЕЦИАЛИЗИРАНИ НАУЧНИ ИЗДАНИЯ (РЕФЕРИРАНИ В МЕЖДУНАРОДНАТА БАЗА ДАННИ – SCOPUS КЪМ 05.08.2010) Scopus
EXPORT DATE: 5 August 2010 Baumgart, D.C., Targan, S.R., Dignass, A.U., Mayer, L., Van Assche, G., Hommes, D.W., Hanauer, S.B., Mahadevan, U., Reinisch, W., Plevy, S.E., Salzberg, B.A., Buchman, A.L., Mechkov, G.M., Krastev, Z.A., Lowder, J.N., Frankel, M.B., Sandborn, W.J. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis (2010) Inflammatory Bowel Diseases, 16 (4), pp. 620-629. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949507036&partnerID=40&md5=31c5313843ee3297753cee61319a79f7 DOCUMENT TYPE: Article SOURCE: Scopus Strauch, U., Schölmerich, J. Emerging drugs to treat Crohn's disease (2010) Expert Opinion on Emerging Drugs, 15 (2), pp. 309-322. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952842168&partnerID=40&md5=6157e54a238dcda5f6ce1e41d9844db1 DOCUMENT TYPE: Review SOURCE: Scopus
Reply to J.J.L. Jacobs et al (2009) Journal of Clinical Oncology, 27 (18), pp. 3063-3064. http://www.scopus.com/inward/record.url?eid=2-s2.0-74549210098&partnerID=40&md5=03ae99bd9f59db09f244cf432072ec4d DOCUMENT TYPE: Letter SOURCE: Scopus Marcellin, P., Heathcote, E.J., Buti, M., Gane, E., De Man, R.A., Krastev, Z., Germanidis, G., Lee, S.S., Flisiak, R., Kaita, K., Manns, M., Kotzev, I., Tchernev, K., Buggisch, P., Weilert, F., Kurdas, O.O., Shiffman, M.L., Trinh, H., Washington, M.K., Sorbel, J., Anderson, J., Snow-Lampart, A., Mondou, E., Quinn, J., Rousseau, F. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B (2008) New England Journal of Medicine, 359 (23), pp. 2442-2455. Cited 109 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-57349095400&partnerID=40&md5=0f59e6ef314bee01578e4b635dec73c8 DOCUMENT TYPE: Article SOURCE: Scopus Tan, H.-H., Martin, P. Management of end-stage liver disease in chronic hepatitis B (2010) Clinics in Liver Disease, 14 (3), pp. 477-493. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954632240&partnerID=40&md5=dfc13c5038c1b0df3b07cb207355bb05 DOCUMENT TYPE: Review SOURCE: Scopus
A review of oral antiretroviral therapy for the treatment of chronic hepatitis B (2010) Annals of Pharmacotherapy, 44 (7-8), pp. 1271-1286. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954593322&partnerID=40&md5=9abdb7ded1fc3b440bd4042860b5c48a DOCUMENT TYPE: Review SOURCE: Scopus Cuestas, M.L., Mathet, V.L., Oubiña, J.R., Sosnik, A. Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection (2010) Pharmaceutical Research, 27 (7), pp. 1184-1202. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953609047&partnerID=40&md5=1bce88157afefdcd9d58e6c6d6309922 DOCUMENT TYPE: Review SOURCE: Scopus De Clercq, E. Antiviral therapy: Quo vadis? (2010) Future Medicinal Chemistry, 2 (7), pp. 1049-1053. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954686776&partnerID=40&md5=876e5bc95689c18d577cc0fb04b7c3b2 DOCUMENT TYPE: Editorial SOURCE: Scopus Hézode, C., Pawlotsky, J.-M. Chronic hepatitis B: Antiviral treatment guidelines [Hépatite chronique B: Principes du traitement antiviral] (2010) Revue du Praticien, 60 (6), pp. 751-758. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954366952&partnerID=40&md5=1ec95eb1b5d096f49de3ef78d0b8163d DOCUMENT TYPE: Review SOURCE: Scopus Yeh, C.-T. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy (2010) Antiviral Therapy, 15 (3 PART B), pp. 471-475. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953441846&partnerID=40&md5=17ecbea77b07893c689ddb0bbec9749a DOCUMENT TYPE: Review SOURCE: Scopus Strasfeld, L., Chou, S. Antiviral drug resistance: Mechanisms and clinical implications (2010) Infectious Disease Clinics of North America, 24 (2), pp. 413-437. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952722362&partnerID=40&md5=abc9e3c33899d89ad4fddf3ed6939a21 DOCUMENT TYPE: Review SOURCE: Scopus Wong, V.W.-S., Wong, G.L.-H., Yan, K.K.-L., Chim, A.M.-L., Chan, H.-Y., Tse, C.-H., Choi, P.C.-L., Chan, A.W.-H., Sung, J.J.-Y., Chan, H.L.-Y. Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B (2010) Hepatology, 51 (6), pp. 1945-1953. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952725714&partnerID=40&md5=f20588ef591e42396c0fbd5940f15d11 DOCUMENT TYPE: Article SOURCE: Scopus Jiang, L., Yan, L.-N. Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation (2010) World Journal of Gastroenterology, 16 (20), pp. 2468-2475. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953248761&partnerID=40&md5=04f6a6a428fa68246b9be148c38c7bff DOCUMENT TYPE: Article SOURCE: Scopus Chien, R.-N. On-treatment monitoring of chronic hepatitis B virus infection: An Asian-Pacific perspective (2010) Journal of Gastroenterology and Hepatology, 25 (5), pp. 852-857. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951752202&partnerID=40&md5=38c2e3c1499e7a0240867b3db4a0b5cf DOCUMENT TYPE: Review SOURCE: Scopus Stine, J.G., Khokhar, O.S., Charalambopoulos, J., Shanmugam, V.K., Lewis, J.H. Rheumatologists' awareness of and screening practices for hepatitis B virus infection prior to initiating immunomodulatory therapy (2010) Arthritis Care and Research, 62 (5), pp. 704-711. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951725797&partnerID=40&md5=8384fd2d5864158e807d12ce62f3170b DOCUMENT TYPE: Article SOURCE: Scopus Marcellin, P., Sung, J., Piratvisuth, T. Avoiding and managing lamivudine resistance in chronic hepatitis B: Current approaches and potential strategies including pegylated interferon (2010) Liver International, 30 (5), pp. 657-668. http://www.scopus.com/inward/record.url?eid=2-s2.0-77954364826&partnerID=40&md5=ebba0791f8cba5b834f219560396a163 DOCUMENT TYPE: Review SOURCE: Scopus Takkenberg, R.B., Weegink, C.J., Zaaijer, H.L., Reesink, H.W. New developments in antiviral therapy for chronic hepatitis B (2010) Vox Sanguinis, 98 (4), pp. 481-494. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951131327&partnerID=40&md5=2c75d691300799241726a9f07d74bb57 DOCUMENT TYPE: Review SOURCE: Scopus Chu, C.-M., Liaw, Y.-F. Hepatitis B surface antigen seroclearance during chronic HBV infection (2010) Antiviral Therapy, 15 (2), pp. 133-143. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950684115&partnerID=40&md5=d9e698db1fd2970bd3f9309105d12435 DOCUMENT TYPE: Review SOURCE: Scopus Lau, G.K.K. Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: A comparison focusing on HBeAg seroconversion (2010) Liver International, 30 (4), pp. 512-520. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950615937&partnerID=40&md5=1812d8cd989ed1f92a70deb174fba3ca DOCUMENT TYPE: Review SOURCE: Scopus Verhelst, X., Orlent, H., Colle, I., Geerts, A., De Vos, M., Van Vlierberghe, H. Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B (2010) European Journal of Gastroenterology and Hepatology, 22 (4), pp. 494-499. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949446497&partnerID=40&md5=0e75b905ff9806aa901e167dcc023652 DOCUMENT TYPE: Article SOURCE: Scopus Giacchino, R., Cappelli, B. Treatment of viral hepatitis B in children (2010) Expert Opinion on Pharmacotherapy, 11 (6), pp. 889-903. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949891974&partnerID=40&md5=6ddc9a85cccfaa73d5bd758f9def91fc DOCUMENT TYPE: Review SOURCE: Scopus Wursthorn, K., Mederacke, I., Manns, M.P. Chronic hepatitis B: Pathophysiology, diagnosis and treatment options (2010) Frontiers of Gastrointestinal Research, 26, pp. 32-41. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949402339&partnerID=40&md5=517beb3dfde55ccda37ced4d68b32508 DOCUMENT TYPE: Review SOURCE: Scopus Perrillo, R.P., Marcellin, P. Effect of newer oral antiviral agents on future therapy of chronic hepatitis B (2010) Antiviral Therapy, 15 (1), pp. 13-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949373357&partnerID=40&md5=47a694acbe186928920d71f163de7277 DOCUMENT TYPE: Review SOURCE: Scopus Wang, L.-C., Chen, E.-Q., Cao, J., Liu, L., Wang, J.-R., Lei, B.-J., Tang, H. Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy (2010) Journal of Viral Hepatitis, 17 (3), pp. 178-184. http://www.scopus.com/inward/record.url?eid=2-s2.0-75149180038&partnerID=40&md5=6ea129c2f24aa6a05ce414e443ec9cf5 DOCUMENT TYPE: Article SOURCE: Scopus Suh, D.J., Um, S.H., Herrmann, E., Kim, J.-H., Lee, Y.S., Lee, H.J., Lee, M.S., Lee, Y.-J., Bao, W., Lopez, P., Lee, H.C., Avila, C., Zeuzem, S. Early viral kinetics of telbivudine and entecavir: Results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B (2010) Antimicrobial Agents and Chemotherapy, 54 (3), pp. 1242-1247. http://www.scopus.com/inward/record.url?eid=2-s2.0-77149167555&partnerID=40&md5=2929d889fb43d88b923b2e45ecee0670 DOCUMENT TYPE: Article SOURCE: Scopus Duarte-Rojo, A., Heathcote, E.J. Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B (2010) Therapeutic Advances in Gastroenterology, 3 (2), pp. 107-119. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953426673&partnerID=40&md5=ed397a93a78a0e7c12b3c87923a61807 DOCUMENT TYPE: Review SOURCE: Scopus Yuen, M.-F., Han, K.-H., Um, S.-H., Yoon, S.-K., Kim, H.-R., Kim, J., Kim, C.R., Lai, C.-L. Antiviral activity and safety of LB80380 in hepatitis B e antigen-positive chronic hepatitis B patients with lamivudine-resistant disease (2010) Hepatology, 51 (3), pp. 767-776. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950606642&partnerID=40&md5=83411fb1233d8af70fe2449b35e80773 DOCUMENT TYPE: Article SOURCE: Scopus Asselah, T., Lada, O., Marcellin, P. Chronic hepatitis B therapy: Results of clinical trials [Résultats des essais thérapeutiques dans l'hépatite chronique B] (2010) Antibiotiques, 12 (1), pp. 42-54. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649232122&partnerID=40&md5=b267b29b0b5fa1c679e7719e0948357b DOCUMENT TYPE: Article SOURCE: Scopus Abbas, Z., Jafri, W., Hamid, S. Management of hepatitis B: Pakistan Society for the Study of Liver Diseases (PSSLD) practice guidelines (2010) Journal of the College of Physicians and Surgeons Pakistan, 20 (3), pp. 198-201. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950488514&partnerID=40&md5=073f054b5bf8c48c86fd308a3eb95c33 DOCUMENT TYPE: Article SOURCE: Scopus Raimondi, S., Maisonneuve, P., Bruno, S., Mondelli, M.U. Is response to antiviral treatment influenced by hepatitis B virus genotype? (2010) Journal of Hepatology, 52 (3), pp. 441-449. http://www.scopus.com/inward/record.url?eid=2-s2.0-77249123832&partnerID=40&md5=f529e44008c1a83155987844eb7987c9 DOCUMENT TYPE: Review SOURCE: Scopus Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F. Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions (2010) Hepatology International, 4 (1), pp. 386-395. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949655951&partnerID=40&md5=a0c54723c56fa28cc6172f7373ec10af DOCUMENT TYPE: Review SOURCE: Scopus Sun, J., Hou, J.L. Management of chronic hepatitis B: Experience from China (2010) Journal of Viral Hepatitis, 17 (SUPPL. 1), pp. 10-17. http://www.scopus.com/inward/record.url?eid=2-s2.0-77749315654&partnerID=40&md5=c3cfd78bf8aaf8b6ee3653d6fc257ff0 DOCUMENT TYPE: Review SOURCE: Scopus Choi, M.S., Yoo, B.C. Management of chronic hepatitis B with nucleoside or nucleotide analogues: A review of current guidelines (2010) Gut and Liver, 4 (1), pp. 15-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949869124&partnerID=40&md5=4066b1e8582ba287ca6a2bf6fbfe5489 DOCUMENT TYPE: Review SOURCE: Scopus De Clercq, E. Highlights in the discovery of antiviral drugs: A personal retrospective (2010) Journal of Medicinal Chemistry, 53 (4), pp. 1438-1450. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649202344&partnerID=40&md5=7c311aa91607e43f8a7d7d06185cd54c DOCUMENT TYPE: Review SOURCE: Scopus Chang, T.-T., Lai, C.-L., Yoon, S.K., Lee, S.S., Coelho, H.S.M., Carrilho, F.J., Poordad, F., Halota, W., Horsmans, Y., Tsai, N., Zhang, H., Tenney, D.J., Tamez, R., Iloeje, U. Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B (2010) Hepatology, 51 (2), pp. 422-430. Cited 2 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-75449107726&partnerID=40&md5=e047b0ced1cfe1846445bdde10c4f6ef DOCUMENT TYPE: Article SOURCE: Scopus Fontana, R.J. Entecavir in decompensated HBV cirrhosis: The future is looking brighter (2010) Journal of Hepatology, 52 (2), pp. 147-149. http://www.scopus.com/inward/record.url?eid=2-s2.0-75449102162&partnerID=40&md5=aa6d53806eae690f02a4a7f9f0bb3bfe DOCUMENT TYPE: Editorial SOURCE: Scopus Tamori, A., Enomoto, M., Kobayashi, S., Iwai, S., Morikawa, H., Sakaguchi, H., Habu, D., Shiomi, S., Imanishi, Y., Kawada, N. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus (2010) Journal of Viral Hepatitis, 17 (2), pp. 123-129. http://www.scopus.com/inward/record.url?eid=2-s2.0-74049135616&partnerID=40&md5=cd8de34ec54df5b6726d53f0d3fc22ec DOCUMENT TYPE: Article SOURCE: Scopus Si Ahmed, S.N., Ecochard, M., Zoulim, F. End points of therapy in chronic hepatitis B (2010) Expert Review of Gastroenterology and Hepatology, 4 (1), pp. 37-49. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951672629&partnerID=40&md5=f2dd9ce9cd4249b9ae4bb6399adda406 DOCUMENT TYPE: Review SOURCE: Scopus Bender, M.A., Kumarasamy, N., Mayer, K.H., Wang, B., Walensky, R.P., Flanigan, T., Schackman, B.R., Scott, C.A., Lu, Z., Kenneth, A. Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India (2010) Clinical Infectious Diseases, 50 (3), pp. 416-425. Cited 4 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-75749104632&partnerID=40&md5=ce23a949b5a8df682f84e72556ebe674 DOCUMENT TYPE: Article SOURCE: Scopus Martin-Carbonero, L., Soriano, V. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients (2010) Journal of Antimicrobial Chemotherapy, 65 (3), art. no. dkp492, pp. 379-382. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950312767&partnerID=40&md5=7235330747e214c768d4cd56b5125e96 DOCUMENT TYPE: Article SOURCE: Scopus Yeung, L.T., Roberts, E.A. Current issues in the management of paediatric viral hepatitis (2010) Liver International, 30 (1), pp. 5-18. http://www.scopus.com/inward/record.url?eid=2-s2.0-73449085495&partnerID=40&md5=73346f19d9ab286e730843e9fa8a00bf DOCUMENT TYPE: Review SOURCE: Scopus Pol, S. Treatment of hepatitis B chronic infection the concern of the hepatologist on the kidney safety [Traitement de l'infection virale B chronique Le point de vue de l'hépatologue sur la tolérance rénale] (2010) Hepato-Gastro, 17 (1), pp. 75-80. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649314224&partnerID=40&md5=f4c219664f26f3ba487b1821caf8e725 DOCUMENT TYPE: Short Survey SOURCE: Scopus Song, B.-C. How to overcome antiviral-resistant hepatitis b virus? (2010) Intervirology, 53 (1), pp. 29-38. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-75349109152&partnerID=40&md5=425b8e4f8eb58cbb5d8edc158985fbfb DOCUMENT TYPE: Conference Paper SOURCE: Scopus Karras, A. Nephrotoxicity of antiviral therapy for hepatitis B the nephrologist's point of view [Néphrotoxicitédes traitements de l'hépatite B Le point de vue du néphrologue] (2010) Hepato-Gastro, 17 (1), pp. 67-72. http://www.scopus.com/inward/record.url?eid=2-s2.0-77649297819&partnerID=40&md5=22cd73353f9a9345a094a75dc150ebb5 DOCUMENT TYPE: Short Survey SOURCE: Scopus Rodríguez, C.M.F., García, M.L.G. New practice guidelines in chronic hepatitis B: Current therapeutic strategies [Nuevas pautas de actuación en la hepatitis B crónica: Estrategias terapéuticas actuales] (2010) Gastroenterologia y Hepatologia Continuada, 9 (1), pp. 11-15. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949309635&partnerID=40&md5=058d447668bfd69cd48bf54e73e36151 DOCUMENT TYPE: Review SOURCE: Scopus Sato, K., Mori, M. Current and novel therapies for hepatitis B virus infection (2010) Mini-Reviews in Medicinal Chemistry, 10 (1), pp. 20-31. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951125274&partnerID=40&md5=8402537ab3510bd73bbdae7a90dc4c45 DOCUMENT TYPE: Review SOURCE: Scopus Sombié, R., Bougouma, A., Diallo, O., Bonkoungou, G., Cissé, R., Sangare, L., Sia, R., Serme, K., Ilboudo, D. Chronic hepatitis B: Epidemiological, diagnosis, therapeutic, and evolutionary aspects in Yalgado-Ouédraogo teaching hospital in Ouagadougou [Hépatite B chronique: Aspects épidémiologique, diagnostique, thérapeutique et évolutif au centre hospitalier universitaire Yalgado Ouédraogo de Ouagadougou] (2010) Journal Africain d'Hepato-Gastroenterologie, 4 (1), pp. 3-10. http://www.scopus.com/inward/record.url?eid=2-s2.0-77951499280&partnerID=40&md5=6f9aeb6b4f53f21bed6c86662cdcece3 DOCUMENT TYPE: Article SOURCE: Scopus Amini-Bavil-Olyaee, S., Vucur, M., Luedde, T., Trautwein, C., Tacke, F. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B Virus e antigen-positive and -negative strains (2010) Journal of Virology, 84 (2), pp. 1026-1033. http://www.scopus.com/inward/record.url?eid=2-s2.0-73849096150&partnerID=40&md5=ef2b2aadfa25047aae1f5131a81c5f9c DOCUMENT TYPE: Article SOURCE: Scopus Tomillero, A., Moral, M.A. Gateways to clinical trials: Summary (2009) Methods and Findings in Experimental and Clinical Pharmacology, 31 (6), pp. 397-417. http://www.scopus.com/inward/record.url?eid=2-s2.0-71949091890&partnerID=40&md5=7ace0391dbadd4d1720693b2aa752df7 DOCUMENT TYPE: Review SOURCE: Scopus Strassburg, C.P., Cornberg, M. Diagnostics and therapy of hepatitis [Diagnostik und Therapie der Hepatitis] (2009) Internist, 50 (12), pp. 1358-1368. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-73649133594&partnerID=40&md5=e4326b41c584b6b83e118e1ff8549f76 DOCUMENT TYPE: Review SOURCE: Scopus Sanchez, M.J., Buti, M., Esteban, R. New European guidelines for the treatment of chronic hepatitis B (2009) Hot Topics in Viral Hepatitis, 5 (15), pp. 19-23. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953463894&partnerID=40&md5=fa0d0db4f7657010a73bb2ec70d79efe DOCUMENT TYPE: Review SOURCE: Scopus Soriano, V., Tuma, P., Vispo, E., Labarga, P., Fernández, J.V., Medrano, J., Barreiro, P. Hepatitis B in HIV patients: What is the current treatment and what are the challenges? (2009) Journal of HIV Therapy, 14 (1), pp. 13-18. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349582324&partnerID=40&md5=a898613f058bac78e6ebbe7b31adc420 DOCUMENT TYPE: Review SOURCE: Scopus Mauss, S. Therapy of chronic hepatitis B: New goals and new treatments (2009) Minerva Medica, 100 (6), pp. 447-458. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949847394&partnerID=40&md5=e59a20a7e862f15d33d3f87e961e155c DOCUMENT TYPE: Review SOURCE: Scopus Moucari, R., Martinot-Peignoux, M., Mackiewicz, V., Boyer, N., Ripault, M.-P., Castelnau, C., Leclere, L., Dauvergne, A., Valla, D., Vidaud, M., Nicolas-Chanoine, M.-H., Marcellin, P. Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a (2009) Antiviral Therapy, 14 (8), pp. 1183-1188. Cited 2 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-73449089431&partnerID=40&md5=2ed525d73553bbd3082f331e1e21f9fb DOCUMENT TYPE: Article SOURCE: Scopus Papatheodoridis, G.V., Cholongitas, E., Archimandritis, A.J., Burroughs, A.K. Current management of hepatitis B virus infection before and after liver transplantation (2009) Liver International, 29 (9), pp. 1294-1305. Cited 2 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449715760&partnerID=40&md5=df5368dc526dbe8362b009622021a2e3 DOCUMENT TYPE: Review SOURCE: Scopus Holness, G., Carriero, D.C., Dieterich, D.T. Hepatitis B therapies and antiviral resistance detection and management (2009) Expert Review of Gastroenterology and Hepatology, 3 (6), pp. 693-699. http://www.scopus.com/inward/record.url?eid=2-s2.0-73449106125&partnerID=40&md5=e06bbaeea6423e2c413c4a1071be771d DOCUMENT TYPE: Review SOURCE: Scopus Gonzalez, S.A., Keeffe, E.B. Chronic hepatitis B and C: Update on therapy (2009) Future Virology, 4 (5), pp. 437-452. http://www.scopus.com/inward/record.url?eid=2-s2.0-73849125384&partnerID=40&md5=dc9cd7755e79b8b218895389fabae67a DOCUMENT TYPE: Review SOURCE: Scopus Lok, A.S.F., McMahon, B.J. Chronic hepatitis B: Update 2009 (2009) Hepatology, 50 (3), pp. 661-662. Cited 36 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349240414&partnerID=40&md5=02f7d6f0dba01ded20814ead90c47674 DOCUMENT TYPE: Short Survey SOURCE: Scopus Da̧browska, M.M., Flisiak, R. Current treatment of chronic hepatitis B [Współczesna terapia przewlekłego zapalenia wa̧troby typu B] (2009) Gastroenterologia Polska, 16 (4), pp. 323-327. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449572250&partnerID=40&md5=39319fe1460fc9d64edb424b3062869a DOCUMENT TYPE: Review SOURCE: Scopus Perry, C.M., Simpson, D. Tenofovir disoproxil fumarate: In chronic hepatitis B (2009) Drugs, 69 (16), pp. 2245-2256. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350518852&partnerID=40&md5=f4aa974552f1e285499015b2f5497938 DOCUMENT TYPE: Review SOURCE: Scopus Dusheiko, G., Burney, T. Current treatment of chronic HBV infection: A European perspective (2009) Current Hepatitis Reports, 8 (4), pp. 141-147. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449514592&partnerID=40&md5=af1c5e9dfa6359425641458a26bd1df5 DOCUMENT TYPE: Review SOURCE: Scopus Eckardt, K.-U., L. Kasiske, B. Abstract
(2009) American Journal of Transplantation, 9 (SUPPL. 3), pp. S1-S157. http://www.scopus.com/inward/record.url?eid=2-s2.0-70450152044&partnerID=40&md5=e2bb17fbd4c9b4f98ba7b5878afcb4db DOCUMENT TYPE: Review SOURCE: Scopus Carey, I., Harrison, P.M. Monotherapy versus combination therapy for the treatment of chronic hepatitis B (2009) Expert Opinion on Investigational Drugs, 18 (11), pp. 1655-1666. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-73849138259&partnerID=40&md5=c7bc504eadc2e883ea8f0405ee43c3a2 DOCUMENT TYPE: Review SOURCE: Scopus Zoulim, F., Locarnini, S. Hepatitis B Virus Resistance to Nucleos(t)ide Analogues (2009) Gastroenterology, 137 (5), pp. 1593-1608.e2. Cited 14 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350095437&partnerID=40&md5=15f3ea8145797c62f24be7bff7c4ce45 DOCUMENT TYPE: Review SOURCE: Scopus Kim, W.R., Terrault, N.A., Pedersen, R.A., Therneau, T.M., Edwards, E., Hindman, A.A., Brosgart, C.L. Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States (2009) Gastroenterology, 137 (5), pp. 1680-1686. Cited 7 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350089249&partnerID=40&md5=896809ec6dd26c1d402f4a7d22908b3e DOCUMENT TYPE: Article SOURCE: Scopus Zeuzem, S., Lange, C.M., Kronenberger, B. Hepatitis B: Management of suboptimal response to oral antiviral therapy (2009) Current Hepatitis Reports, 8 (4), pp. 173-180. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449481642&partnerID=40&md5=4c8d570134a8a4f1ac283d5d83a706b7 DOCUMENT TYPE: Review SOURCE: Scopus Tan, H.-H., Martin, P. Current treatment of chronic HBV infection: A North American perspective (2009) Current Hepatitis Reports, 8 (4), pp. 148-153. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449482063&partnerID=40&md5=6b0237d23c8458a4621272ae6715632c DOCUMENT TYPE: Review SOURCE: Scopus De Clercq, E. Antiviral chemotherapy in 2009: Quo vadis? (2009) Future Virology, 4 (4), pp. 313-315. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350115988&partnerID=40&md5=a12de93384a982211630484a2171fb22 DOCUMENT TYPE: Editorial SOURCE: Scopus Buti, M., Brosa, M., Casado, M.A., Rueda, M., Esteban, R. Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B (2009) Journal of Hepatology, 51 (4), pp. 640-646. Cited 6 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-69949132951&partnerID=40&md5=b7a4d0ccd62b47d4f38425a97d36b021 DOCUMENT TYPE: Article SOURCE: Scopus Bourlière, M., Kahloun, A., Gascou-Tessonnier, G. Analogs and fibrosis regression in hepatitis B (2009) Gastroenterologie Clinique et Biologique, 33 (10-11), pp. 923-929. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350430383&partnerID=40&md5=b05c8a935af97a2e8ae6fb06d74154d1 DOCUMENT TYPE: Short Survey SOURCE: Scopus Jenh, A.M., Thio, C.L., Pham, P.A. Tenofovir for the treatment of hepatitis B virus (2009) Pharmacotherapy, 29 (10), pp. 1212-1227. Cited 4 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349658098&partnerID=40&md5=d96b36fe0114bba1400c72c1222e8038 DOCUMENT TYPE: Article SOURCE: Scopus Kurbegov, A.C., Sokol, R.J. Hepatitis B therapy in children (2009) Expert Review of Gastroenterology and Hepatology, 3 (1), pp. 39-49. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-65549162339&partnerID=40&md5=60bffdd4fe3bf10bc56249a4e4fe7efd DOCUMENT TYPE: Review SOURCE: Scopus Adusumilli, S. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection (2009) Drugs of Today, 45 (9), pp. 679-685. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-75749155056&partnerID=40&md5=cab03549b02551cf099ef59e33271511 DOCUMENT TYPE: Review SOURCE: Scopus De Clercq, E. The history of antiretrovirals: Key discoveries over the past 25 years (2009) Reviews in Medical Virology, 19 (5), pp. 287-299. Cited 6 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-70350708165&partnerID=40&md5=32cfb54ab1ce8de19aa075e85e68c6ff DOCUMENT TYPE: Review SOURCE: Scopus Griffiths, P.D. A perspective on antiviral resistance (2009) Journal of Clinical Virology, 46 (1), pp. 3-8. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-67949118684&partnerID=40&md5=9e71f4b0daaa5c13feb372fa24a70299 DOCUMENT TYPE: Review SOURCE: Scopus Mukherjee, S., Mukherjee, U. Hepatitis B and liver transplantation (2009) Current Drug Therapy, 4 (3), pp. 194-201. http://www.scopus.com/inward/record.url?eid=2-s2.0-73449089455&partnerID=40&md5=ca57199c824990ccb9e5481114157e4f DOCUMENT TYPE: Review SOURCE: Scopus Chotiyaputta, W., Lok, A.S.F. Hepatitis B virus variants (2009) Nature Reviews Gastroenterology and Hepatology, 6 (8), pp. 453-462. Cited 3 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-68549087141&partnerID=40&md5=dcd507bf61da46f1a09ca1217d8eb348 DOCUMENT TYPE: Review SOURCE: Scopus Clercq, E.D. Chapter 1 Looking Back in 2009 at the Dawning of Antiviral Therapy Now 50 Years Ago. An Historical Perspective (2009) Advances in Virus Research, 73, pp. 1-53. Cited 3 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-68549110305&partnerID=40&md5=d67005c05a6228512b4cf287dadebf70 DOCUMENT TYPE: Review SOURCE: Scopus Liaw, Y.-F. Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia (2009) Journal of Hepatology, 51 (2), pp. 403-410. Cited 6 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649224111&partnerID=40&md5=5f5947d788c53c4d9890c6427db39970 DOCUMENT TYPE: Review SOURCE: Scopus Lok, A.S.F. Evolution of nucleoside/tide analogues for hepatitis B: Is the ideal drug here yet? (2009) Journal of Hepatology, 51 (2), pp. 416-418. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649216603&partnerID=40&md5=1b4a2566d7f9e49499bf49a243d41395 DOCUMENT TYPE: Article SOURCE: Scopus Scarsi, K.K., Darin, K.M. Chronic Hepatitis B infection: Principles of therapy (2009) Journal of Pharmacy Practice, 22 (4), pp. 359-387. http://www.scopus.com/inward/record.url?eid=2-s2.0-68449090867&partnerID=40&md5=362d81d719a7e663b6f608ee7568d769 DOCUMENT TYPE: Review SOURCE: Scopus Bowden, S., Shaw, T. Hepatitis B: The case for combination therapy (2009) Current Opinion in Investigational Drugs, 10 (8), pp. 795-803. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-68649114323&partnerID=40&md5=d3499c6ac56a21c67c6df9bd34cfb745 DOCUMENT TYPE: Review SOURCE: Scopus Stránský, J., Kynčl, J. Have we observed any changes in the epidemiology and management of chronic hepatitis B? [Nastaly nějaké změny v epidemiologii a terapii chronické hepatitidy B?] (2009) Prakticky Lekar, 89 (7), pp. 357-360. http://www.scopus.com/inward/record.url?eid=2-s2.0-69949137362&partnerID=40&md5=0f8c1c13072feffef27d2e34c60ae0d1 DOCUMENT TYPE: Article SOURCE: Scopus Wong, V.W.-S., Sung, J.J.-Y. Antiviral therapy for chronic hepatitis B: Are we doing any good to patients? (2009) Journal of Antimicrobial Chemotherapy, 64 (2), pp. 223-226. http://www.scopus.com/inward/record.url?eid=2-s2.0-67650763661&partnerID=40&md5=d79cf92b45abac337b3500cb0b03f782 DOCUMENT TYPE: Editorial SOURCE: Scopus Wong, V.W.-S., Chan, H.L.-Y. Severe acute exacerbation of chronic hepatitis B: A unique presentation of a common disease (2009) Journal of Gastroenterology and Hepatology, 24 (7), pp. 1179-1186. Cited 3 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-68749088893&partnerID=40&md5=ea89ae24633167ce29b0bba9dd5c08e2 DOCUMENT TYPE: Article SOURCE: Scopus Akbar, S.M.F., Hiasa, Y., Mishiro, S., Onji, M. Treatment of hepatitis B virus-infected patients: Utility of therapeutic recommendations in developing countries (2009) Expert Opinion on Pharmacotherapy, 10 (10), pp. 1605-1614. http://www.scopus.com/inward/record.url?eid=2-s2.0-67650463293&partnerID=40&md5=69d41cb1826f17e72ab97093329887a5 DOCUMENT TYPE: Review SOURCE: Scopus De Clercq, E. Another ten stories inantiviraldrug discovery (Part C): "Old" and "new" antivirals, strategies, and perspectives (2009) Medicinal Research Reviews, 29 (4), pp. 611-645. Cited 5 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649744219&partnerID=40&md5=83015e9b293362c18ef0f75add59040b DOCUMENT TYPE: Review SOURCE: Scopus Liaw, Y.-F. HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B (2009) Hepatology International, 3 (3), pp. 425-433. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949146886&partnerID=40&md5=05ce42b0c4d9edc793c7a7e6a8f6894a DOCUMENT TYPE: Review SOURCE: Scopus Lai, C.-L., Yuen, M.-F. The saga of entecavir (2009) Hepatology International, 3 (3), pp. 421-424. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949161844&partnerID=40&md5=0c44dfad26e12b9f550e95de0a768750 DOCUMENT TYPE: Editorial SOURCE: Scopus Vallet-Pichard, A., Mallet, V., Costentin, C.E., Pol, S. Treatment of HBV-related cirrhosis (2009) Expert Review of Anti-Infective Therapy, 7 (5), pp. 527-535. http://www.scopus.com/inward/record.url?eid=2-s2.0-68249162589&partnerID=40&md5=d19e1d4a976c041e68d6d8e2f0e0f9bd DOCUMENT TYPE: Review SOURCE: Scopus Marcellin, P., Bonino, F., Lau, G.K.K., Farci, P., Yurdaydin, C., Piratvisuth, T., Jin, R., Gurel, S., Lu, Z.-M., Wu, J., Popescu, M., Hadziyannis, S. Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a (2009) Gastroenterology, 136 (7), pp. 2169-2179.e4. Cited 12 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-66449121130&partnerID=40&md5=fe39076dbe6b5270658cf3deaecb9e43 DOCUMENT TYPE: Article SOURCE: Scopus Nazzal, K. Treatment of chronic hepatitis B and drug resistance [Leczenie przewlekłego wirusowego zapalenia watroby typu B i lekooporność] (2009) Przeglad Gastroenterologiczny, 4 (1), pp. 7-11. http://www.scopus.com/inward/record.url?eid=2-s2.0-65849360108&partnerID=40&md5=1a5259baa1e587a365050f536c956489 DOCUMENT TYPE: Review SOURCE: Scopus Jiang, L., Jiang, L.-S., Cheng, N.-S., Yan, L.-N. Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation (2009) World Journal of Gastroenterology, 15 (20), pp. 2489-2499. Cited 3 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-67650120123&partnerID=40&md5=53fde820cc1449407ee6642febf439e4 DOCUMENT TYPE: Review SOURCE: Scopus Therapy for chronic hepatitis B: Tenofovir - First choice in the current EASL guidelines [Therapie der chronischen hepatitis B: Tenofovir - Erste wahl in den aktuellen EASL-guidelines] (2009) MMW-Fortschritte der Medizin, 151 (22), pp. 38-39. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649764293&partnerID=40&md5=52f1525090dacc68cdcdfa33550799b8 DOCUMENT TYPE: Short Survey SOURCE: Scopus
Clevudine for hepatitis B (2009) Drugs of Today, 45 (5), pp. 331-350. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-69249176196&partnerID=40&md5=8381cda9c5b08834ab3aba0a8f7ec8c2 DOCUMENT TYPE: Review SOURCE: Scopus Sherman, M. Prevention of hepatocellular carcinoma: The holy grail of hepatitis B treatment (2009) Journal of Hepatology, 50 (5), pp. 854-856. http://www.scopus.com/inward/record.url?eid=2-s2.0-64549110662&partnerID=40&md5=4821ca32aaf7d0392a223b6466469eb2 DOCUMENT TYPE: Editorial SOURCE: Scopus Leroy, V., Pariente, A. Do immunotolerant HBV carriers need to be treated? [Faut-il traiter les porteurs du virus de l'hépatite B au stade d'immunotolérance?] (2009) Hepato-Gastro, 16 (3), pp. 169-172. http://www.scopus.com/inward/record.url?eid=2-s2.0-66749142402&partnerID=40&md5=e77cda7af2367e91dec800f469b3a7dd DOCUMENT TYPE: Editorial SOURCE: Scopus Lampertico, P. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice (2009) Journal of Hepatology, 50 (4), pp. 644-647. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-61749087369&partnerID=40&md5=82fb05ae152564b77a3fc4c6dc5f69f2 DOCUMENT TYPE: Editorial SOURCE: Scopus Yuen, M.-F., Fung, J., Wong, D.K.-H., Lai, C.-L. Prevention and management of drug resistance for antihepatitis B treatment (2009) The Lancet Infectious Diseases, 9 (4), pp. 256-264. Cited 6 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-62549089691&partnerID=40&md5=c27a88bb19de9dd470ae8b9b6ca99252 DOCUMENT TYPE: Review SOURCE: Scopus Di Marco, V., Craxi, A. Chronic hepatitis B: Who to treat and which choice of treatment? (2009) Expert Review of Anti-Infective Therapy, 7 (3), pp. 281-291. Cited 4 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649124578&partnerID=40&md5=ee2f4aa4d9d5c80b7eaa8377a878b944 DOCUMENT TYPE: Article SOURCE: Scopus Ozaras, R., Leblebicioglu, H. How to compare antivirals in the treatment of chronic hepatitis B? (2009) Annals of Clinical Microbiology and Antimicrobials, 8, art. no. 6, . http://www.scopus.com/inward/record.url?eid=2-s2.0-62349117022&partnerID=40&md5=b8b66f9e98d8bca4fb481c05f08d9e05 DOCUMENT TYPE: Editorial SOURCE: Scopus Nguyen, M.H., Keeffe, E.B. Chronic hepatitis B: Early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides (2009) Journal of Viral Hepatitis, 16 (3), pp. 149-155. Cited 6 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-60349129272&partnerID=40&md5=66d1e7e6b9e2e26323d0f785fa97d0a5 DOCUMENT TYPE: Review SOURCE: Scopus Bourlière, M. How to treat hepatitis B in 2009? [Quels traitements pour l'hépatite B en 2009?] (2009) Hepato-Gastro, 16 (2), pp. 77-81. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-67650524731&partnerID=40&md5=d3340c6cb8d1daeb3d5c3aa106ffc841 DOCUMENT TYPE: Editorial SOURCE: Scopus Morgan, M., Keeffe, E.B. Diagnosis and treatment of chronic hepatitis B: 2009 update (2009) Minerva Gastroenterologica e Dietologica, 55 (1), pp. 5-22. Cited 3 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-67649337108&partnerID=40&md5=399d1846dee83d3cdf238b7d7b89056e DOCUMENT TYPE: Review SOURCE: Scopus Ortega Quiroz, R., Garzón O., M.A. Treatment of the hepatitis B [Tratamiento de la hepatitis B] (2009) Revista Colombiana de Gastroenterologia, 24 (SUPPL. 1), pp. 21s-31s. http://www.scopus.com/inward/record.url?eid=2-s2.0-68549104069&partnerID=40&md5=905b8669f24047df003fd119c0e2a5a7 DOCUMENT TYPE: Article SOURCE: Scopus Kaiser, T., Moessner, J., Patel, K., McHutchison, J.G., Tillmann, H.L. Life threatening liver disease during treatment with monoclonal antibodies (2009) BMJ, 338 (7692), p. 485. Cited 1 time. http://www.scopus.com/inward/record.url?eid=2-s2.0-61849160282&partnerID=40&md5=c8ee76207ddac3e31a62acd5c0fbffe7 DOCUMENT TYPE: Article SOURCE: Scopus Nash, K. Telbivudine in the treatment of chronic hepatitis B (2009) Advances in Therapy, 26 (2), pp. 155-169. http://www.scopus.com/inward/record.url?eid=2-s2.0-73449106092&partnerID=40&md5=0336ef510bea7fba913ae2796fb62480 DOCUMENT TYPE: Review SOURCE: Scopus Ørstavik, R. Bedre behandling av hepatitt B (2009) Tidsskrift for den Norske Laegeforening, 129 (5), p. 398. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449506581&partnerID=40&md5=c8b389bd3737ef0d53f46e46980feab3 DOCUMENT TYPE: Article SOURCE: Scopus Rockstroh, J.K. Hot topics in HIV and hepatitis coinfection: Noninvasive diagnosis of liver disease, liver transplantation, and new drugs for treatment ofhepatitis coinfection (2009) HIV Clinical Trials, 10 (2), pp. 110-115. http://www.scopus.com/inward/record.url?eid=2-s2.0-68149131449&partnerID=40&md5=c3a4485bb15e48ba716780900cfc42a4 DOCUMENT TYPE: Review SOURCE: Scopus Lai, C.-L., Yuen, M.-F. Chronic hepatitis B - New goals, new treatment (2008) New England Journal of Medicine, 359 (23), pp. 2488-2491. Cited 13 times. http://www.scopus.com/inward/record.url?eid=2-s2.0-57349148151&partnerID=40&md5=1dd7b4ec6209a9297bc9cccea854e345 DOCUMENT TYPE: Editorial SOURCE: Scopus Каталог: users -> files files -> Списък на публикациите на ст н. с. І ст дтн инж. Оханес Сантурджян до края на 2010 files -> Автобиография професор Атанас Дерменджиев files -> С п и с ъ к №1 на научните доклади и публикации на files -> Иформация за публикациите (2000–2010 г.) На доц. Д-р алберт бенбасат монографии, учебници, студии и др files -> Конкурс за редовен асистент по "Персийска литература и култура" в су "Св. Климент Охридски", където постъпва на работа в Центъра за източни езици и култури към Факултета по класически и нови филологии files -> Богомил николов files -> Биография На член кореспондент проф д-р Владимир Атанасов Овчаров Адрес: Катедра по анатомия и хистология, Медицински факултет, Медицински files -> Сп и с ъ к на публикациите на проф дин Казимир Попконстантинов награди files -> Книга за учителя на първа група в детската градина : Ч. 1 / Под ред на Елка Петрова. София : Нар просв., 1984 Ч. Надежда Витанова и др.; Под ред на Елка Петрова files -> Д ф н донка петканова I. Книги Дамаскините в българската литература Изтегляне 0.82 Mb. Сподели с приятели:
|